Dosimetric Results for Male and Female PTC Patients
| Male PTC patients | Female PTC patients | |||||
| Parameters of iodine kinetics | Hypothyroid (n = 79) | rhTSH (n = 16) | P | Hypothyroid (n = 202) | rhTSH (n = 44) | P |
| Activity (MBq) | 3,480 ± 515 | 3,586 ± 441 | 0.19 | 3,382 ± 644 | 3,161 ± 791 | 0.04 |
| Thyroid uptake (%) | 4.9 ± 2.0 | 4.1 ± 1.3 | 0.14 | 3.9 ± 1.7 | 3.6 ± 1.7 | 0.32 |
| Thyroid half-life (h) | 38.1 ± 19.9 | 32.3 ± 15.5 | 0.22 | 28.0 ± 12.0 | 29.6 ± 14.7 | 0.57 |
| Thyroid cumulated activity (MBq*d) | 406 ± 284 | 298 ± 180 | 0.21 | 242 ± 152 | 225 ± 169 | 0.19 |
| Thyroid residence time (h) | 2.9 ± 2.1 | 2.0 ± 1.1 | 0.16 | 1.8 ± 1.1 | 1.8 ± 1.3 | 0.68 |
| Thyroid dose (Gy) | 1,139 ± 797 | 836 ± 505 | 0.21 | 674 ± 427 | 630 ± 475 | 0.22 |
| Whole-body half-life (h) | 22.7 ± 11.6 | 18.0 ± 6.6 | 0.06 | 18.1 ± 5.1 | 15.9 ± 3.7 | 0.01 |
| Whole-body cumulated activity (MBq*d) | 1,859 ± 557 | 1,754 ± 350 | 0.53 | 1,622 ± 527 | 1,547 ± 548 | 0.46 |
| Whole-body residence time (h) | 12.9 ± 3.4 | 11.8 ± 2.0 | 0.23 | 11.6 ± 3.1 | 11.9 ± 3.9 | 0.86 |
| Remaining-body dose (mGy) | 92 ± 28 | 91 ± 20 | 0.95 | 89 ± 30 | 85 ± 30 | 0.45 |